Sarcopenia and physical function in patients before allogenic stem cell transplantatio

• Conditions: C92.00; C85.9; D46.9; C91.00; Non-Hodgkin lymphoma, unspecified; Myelodysplastic syndrome, unspecified

• Registration Number: DRKS00021425
• Lead Sponsor: niversitätsklinikum Ulm, Kliniken am oberen Eselsberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-03-31
• Study Start: 2020-04-17
• Results First Posted: 2021-04-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 199

Inclusion Criteria

clinical indication and eligibility for stemcell transplanation

Exclusion Criteria

exclusion criteria for exercise tests

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
What: overall survival<br>When: every month<br>How: governmental register data

Secondary Outcome Measures

Name	Time	Method
non relapse mortality, graft versus host disease, duration of stem cell transplantation hospitalization period